Finnish Telestroke Pilot 2007-2009

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by Helsinki University Central Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Kuusankoski Regional Hospital Kuusankoski Finland
Kymenlaakso Central Hospital Kotka Finland
Tampere University Hospital Tampere Finland
Central Hospital of Lapland Rovaniemi Finland
South Carelia Central Hospital Lappeenranta Finland
Länsi-Pohja Central Hospital Kemi Finland
Information provided by:
Helsinki University Central Hospital
ClinicalTrials.gov Identifier:
NCT01136993
First received: June 3, 2010
Last updated: NA
Last verified: June 2010
History: No changes posted
  Purpose

Objective is to describe two years experience from The Finnish Telestroke piloting between Helsinki University Central Hospital (HUCH), Department of Neurology, The Hub, and five hospitals, the spokes. The participating hospitals are from Rovaniemi (Lapland), Kemi (North-West of Finland), Lappeenranta, Kuusankoski and Kotka from South-East of Finland. All the participating hospitals have a stroke unit and the thrombolysis treatment and the follow up of the patients are carried in the treating hospital. The aim of the pilot is to provide these hospitals expertise in thrombolysis treatment during off-hours through teleconsultations.

The teleconsultations were begun between the participating hospitals 05/2007 after about 1 years preparation period. During the preparation period the staff from participating hospitals were trained with simulation training and lectures held by the local staff and the faculty of the Helsinki University hospital.

Telestroke consultation: During two way interactive audio-visual consultation the thrombolysis decision is based on: 1) the consultant going through a check up list of indications and no contraindications to the treatment together with the treating physician and 2) Clinical assessment of NIHSS by the treating physician under guidance of the consultant through the two way video system besides 3) Evaluation of the head CT scan.

The data registered is based on documents made at HUCH and the follow up data provided by the chief neurologist of the other hospitals. 109 teleconsultations have been documented over 2 years period. A unique feature of the Finnish pilot is the high percentage of consultations leading to thrombolysis treatment. Another special feature is that the consultant does the teleconsultation work besides other on call duties.


Condition
Stroke

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Finnish Telestroke Pilot 2007-2009

Resource links provided by NLM:


Further study details as provided by Helsinki University Central Hospital:

Primary Outcome Measures:
  • The percentage of thrombolysis treatments per consultations [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Safety (sICH) and Efficacy (mRS at 3 months) compared with on-site thrombolysis [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 109
Study Start Date: May 2007
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
All bi-directional telestroke consultations

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All teleconsultations on stroke thrombolysis decision between the Hub (HUCH) and the 5 Spokes during 2 years time period.

Criteria

Inclusion Criteria:

  • All stroke patients inside 4.5 hours from the symptom onset considered as thrombolysis candidates by the treating physician of the spoke. In suspected basilar artery thrombosis up to 48 h from symptom onset.

Exclusion Criteria:

  • Symptom onset > 4.5 h
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01136993

Contacts
Contact: Tiina R Sairanen, MD, PhD tiina.sairanen@hus.fi
Contact: Turgut Tatlisumak, MD, PhD turgut.tatlisumak@hus.fi

Locations
Finland
Department of neurology, HUCH Recruiting
Helsinki, Finland
Principal Investigator: Tiina Sairanen, MD, PhD         
Sponsors and Collaborators
Helsinki University Central Hospital
Kuusankoski Regional Hospital Kuusankoski Finland
Kymenlaakso Central Hospital Kotka Finland
Tampere University Hospital Tampere Finland
Central Hospital of Lapland Rovaniemi Finland
South Carelia Central Hospital Lappeenranta Finland
Länsi-Pohja Central Hospital Kemi Finland
Investigators
Principal Investigator: Tiina Sairanen, MD, PhD Department of Neurology, HUCH, Helsinki, Finland
  More Information

Publications:
Responsible Party: Dr. Tiina Sairanen, Department of Neurology, HUCH, Helsinki, Finland
ClinicalTrials.gov Identifier: NCT01136993     History of Changes
Other Study ID Numbers: M1010NL0002
Study First Received: June 3, 2010
Last Updated: June 3, 2010
Health Authority: None due to the nature of the study (Registry), Finland':'

Keywords provided by Helsinki University Central Hospital:
Stroke
Thrombolysis
Telestroke

Additional relevant MeSH terms:
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on July 23, 2014